Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: LaserSight

This article was originally published in The Gray Sheet

Executive Summary

LaserSight: Orlando, Florida-based firm obtains exclusive license from the University of Southern California to commercialize a device designed to improve and further automate photorefractive keratectomy (PRK) with any excimer laser. Company officials say that use of the device would obviate the need for use of a blade to remove the epithelial layer of the cornea, the procedure currently performed as a preliminary step in PRK treatment. Peter McDonnell, MD, professor of Ophthalmology at USC, developed the device with eye experts at the Los Angeles-based Doheny Eye Institute. LaserSight's development-stage Auto-PRK system will incorporate McDonnell's device...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005067

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel